Literature DB >> 10215710

alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role.

Z P Khan1, C N Ferguson, R M Jones.   

Abstract

Clonidine has proved to be a clinically useful adjunct in clinical anaesthetic practice as well as in chronic pain therapy because it has both anaesthetic and analgesic-sparing activity. The more selective alpha-2 adrenoceptor agonists, dexmedetomidine and mivazerol, may also have a role in providing haemodynamic stability in patients who are at risk of peri-operative ischaemia. The side-effects of hypotension and bradycardia have limited the routine use of alpha-2 adrenoceptor agonists. Investigations into the molecular pharmacology of alpha-2 adrenoceptors have elucidated their role in the control of wakefulness, blood pressure and antinociception. We discuss the pharmacology of alpha-2 adrenoceptors and their therapeutic role in this review. The alpha-2 adrenoceptor agonists are agonists at imidazoline receptors which are involved in central blood pressure control. Selective imidazoline agonists are now available for clinical use as antihypertensive agents and their pharmacology is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215710     DOI: 10.1046/j.1365-2044.1999.00659.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  137 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without alpha(2) adrenoceptor activation.

Authors:  Toshifumi Kosugi; Kotaro Mizuta; Tsugumi Fujita; Mikio Nakashima; Eiichi Kumamoto
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 3.  [Strategies for perioperative sympatho-modulation].

Authors:  J Wacker; T Pasch; M C Schaub; M Zaugg
Journal:  Anaesthesist       Date:  2005-04       Impact factor: 1.041

4.  Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.

Authors:  Shao M Tham; James A Angus; Elizabeth M Tudor; Christine E Wright
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

5.  Diuretic effects of medetomidine compared with xylazine in healthy dogs.

Authors:  Md Hasanuzzaman Talukder; Yoshiaki Hikasa
Journal:  Can J Vet Res       Date:  2009-07       Impact factor: 1.310

6.  Neurophysiology of Cancer Pain: From the Laboratory to the Clinic.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

7.  Use of α(2)-Agonists in Neuroanesthesia: An Overview.

Authors:  Ehab Farag; Maged Argalious; Daniel I Sessler; Andrea Kurz; Zeyd Y Ebrahim; Armin Schubert
Journal:  Ochsner J       Date:  2011

8.  α2A-adrenergic heteroreceptors are required for stress-induced reinstatement of cocaine conditioned place preference.

Authors:  Rafael E Perez; Aakash Basu; Bretton P Nabit; Nicholas A Harris; Oakleigh M Folkes; Sachin Patel; Ralf Gilsbach; Lutz Hein; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2020-02-19       Impact factor: 7.853

9.  Patient predictors of dexmedetomidine effectiveness for sedation in intensive care units.

Authors:  Pamela L Smithburger; Randall B Smith; Sandra L Kane-Gill; Philip E Empey
Journal:  Am J Crit Care       Date:  2014-03       Impact factor: 2.228

10.  Dexmedetomidine for refractory adrenergic crisis in familial dysautonomia.

Authors:  Ryan C Dillon; Jose-Alberto Palma; Christy L Spalink; Diana Altshuler; Lucy Norcliffe-Kaufmann; David Fridman; John Papadopoulos; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2016-10-17       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.